Header cover image
  • Investing Ideas
  • /
  • Mexican Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Mexican Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Results

1

0 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

1 companies

Genomma Lab Internacional. de

Market Cap: Mex$18.7b

Genomma Lab Internacional, S.A.B. de C.V., bietet zusammen mit seinen Tochtergesellschaften pharmazeutische und Körperpflegeprodukte hauptsächlich in Mexiko und international an.

LAB B

Mex$19.09

7D

-2.4%

1Y

-15.6%